Danny Brody photo

CANNABIS

Danny Brody

Chief Corporate Officer,

HempFusion

  • Co-founder and Former Vice President of the Green Organic Dutchman Holdings, Ltd.

About Danny

Danny Brody is a co-founder and former vice president of The Green Organic Dutchman Holdings, Ltd., (TGOD). Mr. Brody and his team have been instrumental in capitalizing and listing world-class cannabis companies including Emblem (TSX-V:EMC), TGOD (TSX:TGOD), and PLUS Products (CSE:PLUS). Before entering the cannabis industry in 2014, he spent seven years at two leading independent Canadian brokerage firms.

Danny's Videos

Join Danny Brody to discover how investing in regulatory compliance, creating quality and differentiated products, and building an experienced team is establishing HempFusion as a leading global CBD brand.
Danny Brody is the vice president of Investor Relations at The Green Organic Dutchman Holdings Ltd. or TGOD and has more than 10 years' experience in finance and holds a Chartered Investment Manager (CIM) designation from the Canadian Securities Institute (CSI). He spent eight years in the brokerage industry specializing in fund raising, building and maintaining client portfolios, financial advising, marketing, business development, structuring, advanced due diligence, lead generation, and database management before making the switch to the cannabis industry.
The worldwide cannabis market is in its earliest days - this panel will talk to some of the companies and individuals leading the Canadian sector - and by extension - the worldwide market. As the first G20 country to fully legalize adult-use recreational cannabis - Canada is on the forefront of cannabis cultivation, innovation and finance. Learn from companies and leaders driving the industry forward - and hear what they have to say about what the future holds for the sector and for the investing opportunities therein.

When looking at the potential catalysts for the Canadian cannabis industry, none is more significant than the legalization of recreational cannabis at the federal level. This development will serve as a catalyst to the entire cannabis industry and this panel of licensed medical cannabis producers will discuss how they are in position to capitalize on the burgeoning cannabis industry.